Apollomics, Inc. (APLM)
NASDAQ·Healthcare·Biotechnology
$17.60
-3.40%
Mkt Cap $22.08M
No analyst coverage available
We don't have analyst ratings or price target data for Apollomics, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.